Stock 300111 ZHEJIANG SUNFLOWER GREAT HEALTH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Zhejiang Sunflower Great Health Co., Ltd.

Equities

300111

CNE100000SX9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
2.39 CNY -0.83% Intraday chart for Zhejiang Sunflower Great Health Co., Ltd. +10.65% -21.38%
04-26 Zhejiang Sunflower Great Health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-23 Zhejiang Sunflower Great Health Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,251 2,620 3,583 3,527 3,651 3,913
Enterprise Value (EV) 1 2,645 2,599 3,358 3,322 3,450 3,081
P/E ratio -1.97 x -22.8 x 64 x 66 x -3,260 x 179 x
Yield - - - - - -
Capitalization / Revenue 3.42 x 3.13 x 12.5 x 11.9 x 10.9 x 11.6 x
EV / Revenue 4.02 x 3.11 x 11.7 x 11.2 x 10.3 x 9.11 x
EV / EBITDA -17.1 x -269 x 46.8 x 48.5 x 270 x -502 x
EV / FCF 15.3 x 7.38 x 25.6 x -24.8 x 167 x 13.5 x
FCF Yield 6.54% 13.5% 3.91% -4.03% 0.6% 7.42%
Price to Book 11.4 x 52 x 23.9 x 12.3 x 12.8 x 6.09 x
Nbr of stocks (in thousands) 1,119,800 1,119,800 1,119,800 1,119,800 1,119,800 1,287,211
Reference price 2 2.010 2.340 3.200 3.150 3.260 3.040
Announcement Date 25/04/19 27/04/20 27/04/21 24/04/22 25/04/23 23/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 657.4 836.6 287 297.3 335.9 338.4
EBITDA 1 -154.7 -9.673 71.67 68.53 12.79 -6.132
EBIT 1 -300.7 -76.2 52.76 49.45 -2.845 -23.18
Operating Margin -45.74% -9.11% 18.38% 16.63% -0.85% -6.85%
Earnings before Tax (EBT) 1 -1,143 -89.09 70.96 69.31 4.626 24.9
Net income 1 -1,146 -114.9 55.87 53.42 -1.139 21.75
Net margin -174.38% -13.74% 19.47% 17.97% -0.34% 6.43%
EPS 2 -1.020 -0.1026 0.0500 0.0477 -0.001000 0.0170
Free Cash Flow 1 173.1 352 131.4 -134 20.68 228.7
FCF margin 26.33% 42.08% 45.78% -45.07% 6.16% 67.58%
FCF Conversion (EBITDA) - - 183.3% - 161.65% -
FCF Conversion (Net income) - - 235.15% - - 1,051.56%
Dividend per Share - - - - - -
Announcement Date 25/04/19 27/04/20 27/04/21 24/04/22 25/04/23 23/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 395 - - - - -
Net Cash position 1 - 21.2 226 205 200 832
Leverage (Debt/EBITDA) -2.55 x - - - - -
Free Cash Flow 1 173 352 131 -134 20.7 229
ROE (net income / shareholders' equity) -156% -29.1% 30.4% 19.3% 1.1% 3.91%
ROA (Net income/ Total Assets) -9.05% -3.73% 5.24% 5.17% -0.28% -1.56%
Assets 1 12,662 3,082 1,066 1,034 399.7 -1,395
Book Value Per Share 2 0.1800 0.0400 0.1300 0.2600 0.2600 0.5000
Cash Flow per Share 2 0.1600 0.1300 0.2000 0.1800 0.2100 0.6500
Capex 1 5.1 20.7 22.4 16.9 42.1 10.3
Capex / Sales 0.78% 2.47% 7.79% 5.68% 12.55% 3.04%
Announcement Date 25/04/19 27/04/20 27/04/21 24/04/22 25/04/23 23/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG SUNFLOWER GREAT HEALTH CO., LTD. Stock Zhejiang Sunflower Great Health Co., Ltd.
-21.38% 425M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+33.25% 704B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+28.59% 577B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.55% 348B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.16% 327B
ABBVIE INC. Stock AbbVie Inc.
+4.36% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.81% 234B
NOVARTIS AG Stock Novartis AG
+4.93% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-9.78% 194B
AMGEN INC. Stock Amgen Inc.
-3.69% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300111 Stock
  4. Financials Zhejiang Sunflower Great Health Co., Ltd.